
Janux Therapeutics is a clinical-stage biotech company specializing in immunotherapies designed to trigger tumor-specific immune responses without harming healthy tissue. Utilizing its platform masking technology, Janux develops novel drug candidates that address the limitations of traditional T cell engagers. The company has earned recognition as a Great Place To Work Certification™, highlighting its commitment to fostering an innovative and supportive work environment.
The Director of Clinical Operations will lead the end-to-end management of clinical trial activities at an early-phase oncology program, providing strategic and operational leadership. This involves oversight of CROs, vendors, and clinical sites across U.S. and international regions. The role reports to the VP of Clinical Operations and requires a deep understanding of clinical trial processes, regulatory compliance, and leading cross-functional teams.
Janux Therapeutics is a clinical-stage biotech company specializing in immunotherapies designed to trigger tumor-specific immune responses without harming healthy tissue. Utilizing its platform masking technology, Janux develops novel drug candidates that address the limitations of traditional T cell engagers. The company has earned recognition as a Great Place To Work Certification™, highlighting its commitment to fostering an innovative and supportive work environment.